3 hema-onco Flashcards
low Hgb
low MCV
IDA
Thalassemia
Sideroblastic Anemia
Anemia of Chronic dse
low Hgb
Normal MCV
retic ct <3%
infection drugs lead poisoning acute blood loss anemia of chronic dse renal dse
low hgb
high MCV
drugs
vitamin B12/ folate
immune hemolytic
diamond-blackfan
low hgb
normal MCV
retic >3%
with signs of hemolysis
hereditary spherocytosis hereditary elliptocytosis G6PD sickle cell dse HUS/TTP Mechanical Heart Valve
MC nutritional deficiency in children
IDA
Risk factors of IDA in infants and toddlers
LBW prematurity perinatal blood loss early cord clamping excessive consumption of cows milk
risk factor of IDA in children and adolescents
inc reqt (growth spurt and pregn ancy)
occult/chronic blood loss (peptic ulcer, polyp)
menstrual blood loss
infection with intestinal hookworm, trichuris, plasmodium, helicobater pylori, giardia lamblia
most important clinical sign of IDA
pallor
manifestation of anemia @ hgb 6-10g/dL
mild irritability
manifestation of IDA @ hgb 7-8g/dL
pallor
manifestation of IDA @ hgb <5g/dL
lethargy, anorexia, easy fatigability, systolic flow murmur, high output cardiac failure
koilonychia:
pica:
pagophagia:
plumbism:
koilonychia: spoon nails
pica: desire to eat non-nutritive substance
pagophagia: desire to ingest ice
plumbism: ingest lead
PBS of IDA
microcytic hypochromic RBC (d/t dec Hgb production or faulty function)
response of iron therapy in 12-24hrs
subjective improvement (increase appetite, decrease irritability
response of iron therapy in 36-48hrs
initial bone marrow response (erythroid hyperplasia)
response of iron therapy in 48-72hrs
reticulocystosis w/c peak at 5-7 days
response of iron therapy in 4-30 days
inc hgb level
response of iron therapy in 1-3 months
repletion of iron stores
treatment of IDA
Elemental iron 4-6mg/kg TID x 8 weeks
hallmark of aplastic anemia
peripheral pancytopenia with marrow hypoplasia or aplasia
moderate aplastic anemia
ANC:
PC:
corrected retic ct:
ANC: 500-1000/mm3
PC: 20K-100K/mm3
retic ct: <1%
severe aplastic anemia
ANC:
PC:
corrected retic ct:
ANC: <500
PC: <20K
retic ct: <1%
treatment of choice for aplastic anemia
allogenic hematopoietic stem cell transplant
TOC for aplastic anemia if w/o HLA-matched sibling or donor
immunosuppresive therapy with horse anti-thymocyte globulin and cyclosporine
MC inherited aplastic anemia
Fanconi Anemia
- AR
- 3-14 yo
- cells cant properly repair DNA damage known as interstrand crosslink (abnormal chromosomal fragility)
- inability of fanconi cell to remove O2 free radicals
diagnostic criteria of Shwachman-Diamond syndrome
exocrine pancreatic insufficiency & variable hematologic cytopenia d/t bone marrow failure
Criteria of Diamond Blackfan Syndrome
<1yo
macrocytic anemia w/ no other cytopenia
reticulocytopenia
normal marrow cellularity w/a paucity of erythroid precursors
mainstay of therapy for Diamond Blackfan Syndrome
steroids
treatment of shwachman diamond syndrom
oral pancreatic enzyme replacement
fat soluble vitamins
BT, G-CSF
hematppoietic stem cell transplant
MC inherited enzymatic disorder
Glucose-6-Phosphate Dehydrogenase Deficiency
- x linked
- most important dse of HMP pathway
clinical syndrome of G6PD
- episodic hemolytic anemia induced by infection, drugs, fava beans
- spontaneous chronic non-spherocytic hemolytic anemia
PBS of G6PD deficiency
low hgb
heinz bodies
anisopoikilocytosis
bite cells
Manifestation of Alpha Thalassemia
Hydrops Fetalis w/ Barts Hgb: SEVERE MICROCYTIC anemia
Thalassemia Major: MOD MICROCYTIC anemia
Thalassemia Minor: MILD MICROCYTIC anemia
Silent Carrier: Normal hgb and MCV
Manifestation of Beta Thalassemia
B thalassemia Major: SEVERE MICROCYTIC anemia with TARGET CELLS; transfusion dependent
B thalassemia Intermedia: MOD MICROCYTIC anemia; nontransfusion dependent
B thalassemia Minor/trait: MILD MIRCOCYTIC anemia
PBS of thalassemia
microcytic hypochromic RBC
target cell
Heinz bodies
MC cause of hemolytic anemia d/t red cell membrane defect
Hereditary Spherocytosis
- d/t abnormalities of ankyrin & spectrin (proteins involved in RBC cytoskeleton)